Clinical Applications of Stem Cells, 24-25 February 2016, Singapore

Select Biosciences South East Asia is pleased to present the Second Annual Clinical Applications of Stem Cells, taking place on the 24-25 February 2016.

Building on the success of 2015, we look forward to again bringing together researchers, clinicians, the regulatory bodies, academia and industry to discuss translating basic discoveries in the stem cells field into applications for regenerative medicine and cellular therapy.

The meeting will run over two full days, with presentations and key networking opportunities leading into panel discussions each afternoon to cover the points raised during the earlier sessions. Attending this conference will provide you with a detailed overview of the current research, clinical practices and regulatory requirements in this rapidly developing field.

We hope you can join us.

We are pleased to introduce the following highly distinguished experts who comprise the Organising Committee for 2016.

* Lawrence Stanton, Associate Director, Genome Institute of Singapore

* Shigeki Sugii, Group Leader/Assistant Professor, Singapore Bioimaging Consortium/Duke NUS Graduate Medical School

* Karl Tryggvason, Professor, Duke-NUS Graduate Medical School & Karolinska Institutet, Stockholm

* Mari Dezawa, Professor and Chair, Department of Stem Cell Biology and Histology & Department of Anatomy and Anthropology, Tohoku University

* Edward Lanphier, President/Chief Executive Officer, Sangamo BioSciences Inc / Chairman, The Alliance for Regenerative Medicine

* Teck Sin Lim, Founder, Adigenics

Paul Raggett, CEO
[email protected]
+65 9186 3246

From 24 Feb 2016
Until 25 Feb 2016
The Academia, SGH Campus, Singapore
News topics: